160 related articles for article (PubMed ID: 32839152)
1. Cytomorphologic characteristics of next-generation sequencing-positive bile duct brushing specimens.
Rosenbaum MW; Arpin R; Limbocker J; Casey B; Le L; Dudley J; Iafrate AJ; Pitman MB
J Am Soc Cytopathol; 2020; 9(6):520-527. PubMed ID: 32839152
[TBL] [Abstract][Full Text] [Related]
2. Next-Generation Sequencing and Fluorescence in Situ Hybridization Have Comparable Performance Characteristics in the Analysis of Pancreaticobiliary Brushings for Malignancy.
Dudley JC; Zheng Z; McDonald T; Le LP; Dias-Santagata D; Borger D; Batten J; Vernovsky K; Sweeney B; Arpin RN; Brugge WR; Forcione DG; Pitman MB; Iafrate AJ
J Mol Diagn; 2016 Jan; 18(1):124-30. PubMed ID: 26596524
[TBL] [Abstract][Full Text] [Related]
3. Tiny but mighty: use of next generation sequencing on discarded cytocentrifuged bile duct brushing specimens to increase sensitivity of cytological diagnosis.
Harbhajanka A; Michael CW; Janaki N; Gokozan HN; Wasman J; Bomeisl P; Yoest J; Sadri N
Mod Pathol; 2020 Oct; 33(10):2019-2025. PubMed ID: 32457409
[TBL] [Abstract][Full Text] [Related]
4. Bile duct involvement by hepatocellular carcinoma: A rare occurrence and poor prognostic indicator in bile duct brushing samples.
Bhattarai S; Graham RP; Sigel CS; Shi J; Gonzalez RS; Xue Y; Krasinskas AM; HooKim K; Adsay V; Reid MD
Cancer Cytopathol; 2019 Nov; 127(11):691-699. PubMed ID: 31518056
[TBL] [Abstract][Full Text] [Related]
5. Cytologic diagnosis of adenocarcinoma on bile duct brushings in the presence of stent associated changes: A retrospective analysis.
Goyal A; Sharaiha RZ; Alperstein SA; Siddiqui MT
Diagn Cytopathol; 2018 Oct; 46(10):826-832. PubMed ID: 30144340
[TBL] [Abstract][Full Text] [Related]
6. Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts.
Jones M; Zheng Z; Wang J; Dudley J; Albanese E; Kadayifci A; Dias-Santagata D; Le L; Brugge WR; Fernandez-del Castillo C; Mino-Kenudson M; Iafrate AJ; Pitman MB
Gastrointest Endosc; 2016 Jan; 83(1):140-8. PubMed ID: 26253016
[TBL] [Abstract][Full Text] [Related]
7. Factors Impacting the Performance Characteristics of Bile Duct Brushings: A Clinico-Cytopathologic Analysis of 253 Patients.
Hacihasanoglu E; Memis B; Pehlivanoglu B; Avadhani V; Freedman AA; Goodman MM; Adsay NV; Reid MD
Arch Pathol Lab Med; 2018 Jul; 142(7):863-870. PubMed ID: 29582676
[TBL] [Abstract][Full Text] [Related]
8. The Cytomorphologic and Molecular Assessment of Bile Duct Brushing Specimens.
Hilburn CF; Pitman MB
Surg Pathol Clin; 2022 Sep; 15(3):469-478. PubMed ID: 36049829
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic bile duct brushing of malignant pancreatic biliary strictures: retrospective study with comparison of conventional smear and ThinPrep techniques.
Ylagan LR; Liu LH; Maluf HM
Diagn Cytopathol; 2003 Apr; 28(4):196-204. PubMed ID: 12672095
[TBL] [Abstract][Full Text] [Related]
10. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures.
Kipp BR; Stadheim LM; Halling SA; Pochron NL; Harmsen S; Nagorney DM; Sebo TJ; Therneau TM; Gores GJ; de Groen PC; Baron TH; Levy MJ; Halling KC; Roberts LR
Am J Gastroenterol; 2004 Sep; 99(9):1675-81. PubMed ID: 15330900
[TBL] [Abstract][Full Text] [Related]
11. Next-generation sequencing adds value to the preoperative diagnosis of pancreatic cysts.
Rosenbaum MW; Jones M; Dudley JC; Le LP; Iafrate AJ; Pitman MB
Cancer Cytopathol; 2017 Jan; 125(1):41-47. PubMed ID: 27647802
[TBL] [Abstract][Full Text] [Related]
12. Intraductal papillary neoplasm of the bile duct: Cytomorphologic and molecular features.
Stendahl K; Gilani SM; Basturk O; Hui P; Sigel C; Cai G
Cancer Cytopathol; 2023 Jan; 131(1):37-49. PubMed ID: 36041224
[TBL] [Abstract][Full Text] [Related]
13. Role of Ancillary Techniques in Biliary Cytopathology Specimens.
Layfield L
Acta Cytol; 2020; 64(1-2):175-181. PubMed ID: 31121596
[TBL] [Abstract][Full Text] [Related]
14. Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma Demonstrates High Intertumor and Intratumor Heterogeneity.
Kamp EJCA; Peppelenbosch MP; Doukas M; Verheij J; Ponsioen CY; van Marion R; Bruno MJ; Groot Koerkamp B; Dinjens WNM; de Vries AC
Clin Transl Gastroenterol; 2021 Oct; 12(10):e00410. PubMed ID: 34608877
[TBL] [Abstract][Full Text] [Related]
15. Significance of KRAS mutation testing in biliary brushing cytology specimens: A 10-year retrospective review.
Sun T; Zuo T; Hui P; Cai G
Cancer Cytopathol; 2022 Jul; 130(7):558-565. PubMed ID: 35417072
[TBL] [Abstract][Full Text] [Related]
16. Cytologic predictors of malignancy in bile duct brushings: a multi-reviewer analysis of 60 cases.
Avadhani V; Hacihasanoglu E; Memis B; Pehlivanoglu B; Hanley KZ; Krishnamurti U; Krasinskas AM; Osunkoya AO; Daniels LM; Freedman AA; Goodman M; Adsay V; Reid MD
Mod Pathol; 2017 Sep; 30(9):1273-1286. PubMed ID: 28664934
[TBL] [Abstract][Full Text] [Related]
17. UroVysion Multi-Target Fluorescence in situ Hybridization Assay for the Detection of Malignant Bile Duct Brushing Specimens: A Comparison with Routine Cytology.
Zhai J
Acta Cytol; 2018; 62(4):295-301. PubMed ID: 29734171
[TBL] [Abstract][Full Text] [Related]
18. Effect of single operator cholangioscopy on accuracy of bile duct cytology.
Aly FZ; Mostofizadeh S; Jawaid S; Knapik J; Mukhtar F; Klein R
Diagn Cytopathol; 2020 Dec; 48(12):1230-1236. PubMed ID: 32770823
[TBL] [Abstract][Full Text] [Related]
19. Analysis of loss of heterozygosity in atypical and negative bile duct brushing cytology specimens with malignant outcome: are "false-negative" cytologic findings a representation of morphologically subtle molecular alterations?
Krishnamurti U; Sasatomi E; Swalsky PA; Finkelstein SD; Ohori NP
Arch Pathol Lab Med; 2007 Jan; 131(1):74-80. PubMed ID: 17227126
[TBL] [Abstract][Full Text] [Related]
20. NGS of brush cytology samples improves the detection of high-grade dysplasia and cholangiocarcinoma in patients with primary sclerosing cholangitis: A retrospective and prospective study.
Boyd S; Mustamäki T; Sjöblom N; Nordin A; Tenca A; Jokelainen K; Rantapero T; Liuksiala T; Lahtinen L; Kuopio T; Kytölä S; Mäkisalo H; Färkkilä M; Arola J
Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38551383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
